Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Cross-Sectional Studies [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
IS1 [NCBI] 0.00397049
apnea, obstructive sleep [NCBI] 0.00331549
MDD [NCBI] 0.00158448
RA [NCBI] 0.00130573
PTH [NCBI] 0.00072892
CF [NCBI] 0.000677938
SHBG [NCBI] 0.000625673
testicular microlithiasis [NCBI] 0.000587628
stature quantitative trait locus 3 [NCBI] 0.000523945
speech-sound disorder [NCBI] 0.000523945
MAFD6 [NCBI] 0.000489574
AD [NCBI] 0.00047285
SLE [NCBI] 0.000416298
duane retraction syndrome 2 [NCBI] 0.000409023
sjogren syndrome [NCBI] 0.000322459
APOE [NCBI] 0.000306809
ETL2 [NCBI] 0.000306368
DURS1 [NCBI] 0.000265978
abdominal obesity-metabolic syndrome [NCBI] 0.000233969
aneurysm, intracranial berry, 1 [NCBI] 0.000224662
RNASE3 [NCBI] 0.000194336
restless legs syndrome, susceptibility to, 1 [NCBI] 0.000172552
thrombocytopenic purpura, autoimmune [NCBI] 0.00011743
SRS [NCBI] 0.000114589
PEE1 [NCBI] 0.000111011
TNFRSF11B [NCBI] 0.000100241
VDR [NCBI] 9.40596e-05
EPO [NCBI] 9.3826e-05
EGF [NCBI] 9.33257e-05
APC [NCBI] 8.94626e-05
hemoglobin, high oxygen saturation of [NCBI] 8.62222e-05
KLK3 [NCBI] 8.32385e-05
NGFB [NCBI] 7.88652e-05
COMP [NCBI] 7.66717e-05
danubian endemic familial nephropathy [NCBI] 7.02059e-05
XFS [NCBI] 6.36427e-05
HFM [NCBI] 6.16057e-05
ADHD [NCBI] 6.01617e-05
acne, adult [NCBI] 5.87209e-05
achondrogenesis, type iii [NCBI] 5.87209e-05
achondrogenesis, type iv [NCBI] 5.87209e-05
GTS [NCBI] 5.84911e-05
ACE [NCBI] 5.33811e-05
MPO [NCBI] 5.23122e-05
CRC [NCBI] 5.0853e-05
lymphoma, non-hodgkin, familial [NCBI] 4.9757e-05
micromelic bone dysplasia with cloverleaf skull [NCBI] 4.85103e-05
ALB [NCBI] 4.7216e-05
CD [NCBI] 4.6911e-05
ACHE [NCBI] 4.47142e-05
EGFR [NCBI] 4.37294e-05
TH [NCBI] 4.33742e-05
APOB [NCBI] 4.19207e-05
ADIPOQ [NCBI] 3.85785e-05
GFAP [NCBI] 3.82345e-05
ARMD1 [NCBI] 3.79551e-05
CVG/MR [NCBI] 3.71856e-05
isoproterenol-mediated vasodilatation [NCBI] 3.71856e-05
TCF7L2 [NCBI] 3.70804e-05
AT [NCBI] 3.36133e-05
PCNA [NCBI] 3.35696e-05
glaucoma, normal tension, susceptibility to [NCBI] 3.34241e-05
HOA [NCBI] 3.34241e-05
HP [NCBI] 3.31133e-05
homocysteinemia [NCBI] 3.28775e-05
VIP [NCBI] 3.18741e-05
TD2 [NCBI] 3.03419e-05
ACH [NCBI] 2.91106e-05
AMH [NCBI] 2.83805e-05
alopecia, androgenetic [NCBI] 2.82437e-05
ehlers-danlos syndrome, type iii [NCBI] 2.77426e-05
panencephalitis, subacute sclerosing [NCBI] 2.74871e-05
WAS [NCBI] 2.73195e-05
FBL [NCBI] 2.6226e-05
iron overload in africa [NCBI] 2.55043e-05
RBP4 [NCBI] 2.49542e-05
CVID [NCBI] 2.43679e-05
MBL2 [NCBI] 2.37284e-05
POAG [NCBI] 2.37268e-05
HD [NCBI] 2.33643e-05
PYY2 [NCBI] 2.31311e-05
MG [NCBI] 2.30294e-05
PAI1 [NCBI] 2.29572e-05
amyloidosis vi [NCBI] 2.22481e-05
ehlers-danlos syndrome, type ii [NCBI] 2.18119e-05
CFH [NCBI] 2.16575e-05
HPS [NCBI] 2.14036e-05
SLPI [NCBI] 2.0079e-05
SLC34A2 [NCBI] 1.96427e-05
GRB14 [NCBI] 1.96427e-05
CDKAL1 [NCBI] 1.96427e-05
GPD1 [NCBI] 1.96427e-05
NPY [NCBI] 1.96003e-05
PWS [NCBI] 1.89785e-05
pearson marrow-pancreas syndrome [NCBI] 1.88618e-05
crouzon syndrome [NCBI] 1.88618e-05
OPPG [NCBI] 1.88618e-05
LPL [NCBI] 1.77203e-05
erythrocytosis, familial, 2 [NCBI] 1.75918e-05
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 [NCBI] 1.75918e-05
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive [NCBI] 1.75918e-05
IL6 [NCBI] 1.75839e-05
SLC30A8 [NCBI] 1.74849e-05
LCN2 [NCBI] 1.69265e-05
FTD [NCBI] 1.66566e-05
ADLTE [NCBI] 1.64321e-05
NPPA [NCBI] 1.60438e-05
AVP [NCBI] 1.59573e-05
helicobacter pylori infection, susceptibility to [NCBI] 1.53681e-05
SYCP3 [NCBI] 1.52786e-05
HGF [NCBI] 1.52408e-05
HFE [NCBI] 1.49581e-05
INSIG2 [NCBI] 1.47008e-05
acromegaly [NCBI] 1.43877e-05
diarrhea 1, secretory chloride, congenital [NCBI] 1.43877e-05
CTGF [NCBI] 1.43199e-05
MTHFR [NCBI] 1.40539e-05
CLCN7 [NCBI] 1.36992e-05
COL6A3 [NCBI] 1.36992e-05
OGN [NCBI] 1.36992e-05
COL6A2 [NCBI] 1.36992e-05
factor xii deficiency [NCBI] 1.34811e-05
CPI [NCBI] 1.30359e-05
3-@hydroxy-3-methylglutaryl-coa lyase deficiency [NCBI] 1.28522e-05
F3 [NCBI] 1.27881e-05
bethlem myopathy [NCBI] 1.26402e-05
PD [NCBI] 1.21345e-05
PGF [NCBI] 1.21195e-05
DA2A [NCBI] 1.18578e-05
stroke, ischemic [NCBI] 1.18578e-05
ANGPTL4 [NCBI] 1.17875e-05
GNB3 [NCBI] 1.17875e-05
VEGF [NCBI] 1.16056e-05
IL7 [NCBI] 1.1475e-05
NCOA1 [NCBI] 1.1475e-05
PG [NCBI] 1.14079e-05
ETM1 [NCBI] 1.11283e-05
CCK [NCBI] 1.112e-05
CTSD [NCBI] 1.06353e-05
FLT1 [NCBI] 1.06353e-05
TNFSF6 [NCBI] 1.05993e-05
ehlers-danlos syndrome, type i [NCBI] 1.04466e-05
DMD [NCBI] 1.04118e-05
IL1RN [NCBI] 1.0383e-05
CAT [NCBI] 1.02606e-05
UCP2 [NCBI] 1.02244e-05
PINK1 [NCBI] 9.91264e-06
IGFALS [NCBI] 9.69299e-06
LRP5 [NCBI] 9.69278e-06
KL [NCBI] 9.08553e-06
LAM [NCBI] 9.05424e-06
COMT [NCBI] 8.75609e-06
PTX3 [NCBI] 8.71836e-06
ehlers-danlos syndrome, type iv, autosomal dominant [NCBI] 8.64716e-06
CYP11B2 [NCBI] 8.5446e-06
IL1B [NCBI] 8.5446e-06
AGER [NCBI] 8.41504e-06
WBS [NCBI] 8.40211e-06
glycogen storage disease ixa [NCBI] 8.37683e-06
IL1A [NCBI] 8.37683e-06
COL6A1 [NCBI] 8.37683e-06
CXCL12 [NCBI] 8.21471e-06
GHRL [NCBI] 7.75897e-06
DFNB1 [NCBI] 7.62011e-06
PLTP [NCBI] 7.49208e-06
LTA [NCBI] 7.47794e-06
GRN [NCBI] 7.08606e-06
GLA [NCBI] 6.72536e-06
mycobacterium tuberculosis, susceptibility to [NCBI] 6.70757e-06
apert syndrome [NCBI] 6.70757e-06
STGD1 [NCBI] 6.70757e-06
TPO [NCBI] 6.58415e-06
tyrosinemia, type i [NCBI] 6.50017e-06
PRL [NCBI] 6.48791e-06
MLL [NCBI] 6.08195e-06
TYMS [NCBI] 5.93647e-06
PEDF [NCBI] 5.92233e-06
TFPI [NCBI] 5.80418e-06
CYP2D6 [NCBI] 5.79317e-06
CEACAM5 [NCBI] 5.76323e-06
TG [NCBI] 5.61663e-06
PROCR [NCBI] 5.61119e-06
BDNF [NCBI] 5.60564e-06
ADA [NCBI] 5.55306e-06
ALD [NCBI] 5.43869e-06
CRH [NCBI] 5.3412e-06
CEL [NCBI] 5.26989e-06
IGF2 [NCBI] 5.26989e-06
LGMD2A [NCBI] 5.16675e-06
IGF1 [NCBI] 5.10956e-06
CFTR [NCBI] 5.06012e-06
NOS3 [NCBI] 5.03179e-06
ITGB3 [NCBI] 4.95554e-06
MMP2 [NCBI] 4.88076e-06
GPT [NCBI] 4.59554e-06
GCCR [NCBI] 4.59554e-06
CADASIL [NCBI] 4.51557e-06
drug metabolism, poor, cyp2d6-related [NCBI] 4.51557e-06
EIG [NCBI] 4.41995e-06
AQP2 [NCBI] 4.39509e-06
ANG [NCBI] 4.39509e-06
DHFR [NCBI] 4.315e-06
fabry disease [NCBI] 4.28908e-06
MC4R [NCBI] 4.26733e-06
SMA3 [NCBI] 4.21576e-06
OPA1 [NCBI] 4.21576e-06
SLC4A1 [NCBI] 4.14398e-06
AKR1B1 [NCBI] 4.06338e-06
APOA1 [NCBI] 3.96672e-06
CJD [NCBI] 3.86501e-06
CCL22 [NCBI] 3.85342e-06
CTNS [NCBI] 3.66302e-06
GLC1A [NCBI] 3.66302e-06
GAPDH [NCBI] 3.58764e-06
VHL [NCBI] 3.48467e-06
LCT [NCBI] 3.43525e-06
melanoma, uveal [NCBI] 3.40843e-06
TNFRSF1A [NCBI] 3.24501e-06
LBP [NCBI] 3.24501e-06
G6PD [NCBI] 3.14794e-06
PCD [NCBI] 3.03046e-06
POMC [NCBI] 2.95191e-06
IDDM [NCBI] 2.95159e-06
CNTF [NCBI] 2.79573e-06
LMNA [NCBI] 2.7766e-06
CPB2 [NCBI] 2.58687e-06
MYOC [NCBI] 2.55048e-06
KSS [NCBI] 2.50733e-06
XDH [NCBI] 2.39116e-06
MAOA [NCBI] 2.3758e-06
TNF [NCBI] 2.31631e-06
PLAUR [NCBI] 2.30916e-06
PTHLH [NCBI] 2.28313e-06
RNASE2 [NCBI] 2.21247e-06
ESR1 [NCBI] 2.18108e-06
INS [NCBI] 2.15561e-06
TPMT [NCBI] 2.08935e-06
GNRH1 [NCBI] 2.01575e-06
MS [NCBI] 1.92875e-06
AFP [NCBI] 1.75221e-06
obesity [NCBI] 1.50933e-06
sickle cell anemia [NCBI] 1.50933e-06
NF2 [NCBI] 1.50933e-06
UCP1 [NCBI] 1.49173e-06
MBP [NCBI] 1.47726e-06
PON1 [NCBI] 1.44744e-06
FRDA [NCBI] 1.40946e-06
MECP2 [NCBI] 1.36209e-06
STAT5A [NCBI] 1.36209e-06
temporal arteritis [NCBI] 1.33799e-06
SLC2A4 [NCBI] 1.20346e-06
LEP [NCBI] 1.20346e-06
MUC1 [NCBI] 1.11687e-06
SCZD [NCBI] 1.09962e-06
PPARA [NCBI] 1.06276e-06
VHL [NCBI] 1.02703e-06
TLR4 [NCBI] 9.4295e-07
TS [NCBI] 8.35507e-07
leber optic atrophy [NCBI] 7.9239e-07
GJB2 [NCBI] 7.16913e-07
BCNS [NCBI] 6.49818e-07
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 6.42556e-07
PF4 [NCBI] 5.89275e-07
FFI [NCBI] 5.78099e-07
TTR [NCBI] 5.41742e-07
RP [NCBI] 3.91049e-07
FMR1 [NCBI] 3.88426e-07
phenylketonuria [NCBI] 3.31538e-07
AR [NCBI] 3.14642e-07
PLG [NCBI] 3.0154e-07
TD1 [NCBI] 2.97455e-07
CYP1A1 [NCBI] 2.84325e-07
RB1 [NCBI] 2.53213e-07
TF [NCBI] 2.22688e-07
SDC2 [NCBI] 2.15817e-07
MAS [NCBI] 2.07246e-07
PGR [NCBI] 1.82785e-07
PYY [NCBI] 1.44469e-07
SERPINA6 [NCBI] 1.37405e-07
NF1 [NCBI] 9.99179e-08
glycogen storage disease ii [NCBI] 9.54194e-08
FMF [NCBI] 9.19968e-08
IAPP [NCBI] 8.54e-08
GHR [NCBI] 8.19695e-08
TP53 [NCBI] 6.3015e-08
ACP5 [NCBI] 4.56301e-08
PI [NCBI] 3.52126e-08
LDLR [NCBI] 4.41929e-09
PMCH [NCBI] 3.76056e-09
LCAT [NCBI] 3.76056e-09
SLC6A4 [NCBI] 2.09759e-09
CCD [NCBI] 8.534e-12



Database Center for Life Science